$4.54
0.040.89%
Last update: Nov 6, 7:59 PM
Lexaria Bioscience Corp
LEXXNASDAQ
The average analyst price target for Lexaria Bioscience is $101.25, 2236.6% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $22.50 to $180. The latest change came on Dec 26, 2025, when HC Wainwright & Co. lowered its price target on Lexaria Bioscience from $60 to $22.50 and kept a Buy rating.
Price Target Range — 6 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
